EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Invasive Pneumococcal Disease After Hematopoietic Cell Transplantation for Sickle Cell Disease

Diego R Hijano, Caitlin Elgarten iD, Elizabeth Stenger, Katie Liu, Ann E Haight, Suhag H Parikh iD, Julia Gliwinski, Laurence Wechsler, Allistair Abraham, Mauricio Barreto, Timothy S Olson iD, Gabriela Maron iD und 1 weitere

Transplant Infectious Disease · 2026

DOI: 10.1111/tid.70271 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Transplant Infectious Disease, 2026. Verfasst von Diego R Hijano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Hematopoietic Stem Cell Transplantation, Pneumococcal Infections. Die Arbeit nennt 11 Literaturangaben. Gefördert von: National Heart, Lung, and Blood Institute of the National Institutes of Health, American Lebanese Syrian Associated Charities, Merck Sharp & Dohme LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Children with sickle cell disease (SCD) remain at risk for invasive pneumococcal disease (IPD) because of impaired splenic function and increased susceptibility to encapsulated bacteria. Data describing IPD after allogeneic hematopoietic cell transplantation (HCT) for SCD are limited.

Methods

We conducted a multicenter retrospective cohort study of children and young adults with SCD undergoing first allogeneic HCT at two participating Sickle Cell Transplant Advocacy and Research (STAR) centers. IPD occurring within 365 days after HCT was identified through registry data, microbiologic culture review, and supplemental chart review.

Results

Among 182 patients undergoing HCT, three developed IPD within the first year after transplant. All cases presented with sepsis and bacteremia; one patient also developed meningitis and died of septic shock. IPD occurred between 7 and 365 days after HCT. None of the patients had received post‐transplant pneumococcal vaccination before IPD diagnosis. Serotype data were unavailable for all cases.

Conclusion

In this multicenter cohort of patients with SCD undergoing allogeneic HCT, IPD was uncommon but clinically severe, including late infections occurring nearly one year after transplantation. Prospective studies evaluating immune recovery, splenic function, pneumococcal vaccination practices, and long‐term infectious outcomes are needed to better define persistent susceptibility to invasive pneumococcal disease after HCT in patients with SCD. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellHematopoietic Stem Cell TransplantationPneumococcal InfectionsAdolescentAdultChildChild, PreschoolFemaleHumansMaleYoung AdultBacteremiaPneumococcal VaccinesRetrospective StudiesSepsisStreptococcus pneumoniaeTransplantation, Homologous

Stichwörter der Autor:innen

Streptococcus pneumoniaehematopoietic cell transplantationinvasive pneumococcal diseasepediatric infectionpneumococcal vaccinationsickle cell diseasetransplantation

Substanzen

Pneumococcal Vaccines

Autor:innen und Institutionen

  • Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Department of Pediatrics, Cellular Therapy and Transplantation Section, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Pediatrics, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Department of Pediatrics, Pediatric Biostatistics Core, Emory School of Medicine, Atlanta, Georgia, USA.
  • Center For Cancer and Immunology Research, CETI, Children's National Hospital, Washington, DC, USA.

ORCID-Profile: Caitlin Elgarten, Suhag H Parikh, Timothy S Olson, Gabriela Maron

Förderung

  • National Heart, Lung, and Blood Institute of the National Institutes of Health
  • American Lebanese Syrian Associated Charities
  • Merck Sharp & Dohme LLC

Zitieren

APA

Hijano, D. R., Elgarten, C., Stenger, E., Liu, K., Haight, A. E., Parikh, S. H., Gliwinski, J., Wechsler, L., Abraham, A., Barreto, M., Olson, T. S., Maron, G., & Sharma, A. (2026). Invasive Pneumococcal Disease After Hematopoietic Cell Transplantation for Sickle Cell Disease. Transplant Infectious Disease. https://doi.org/10.1111/tid.70271

Vancouver

Hijano DR, Elgarten C, Stenger E, Liu K, Haight AE, Parikh SH, et al. Invasive Pneumococcal Disease After Hematopoietic Cell Transplantation for Sickle Cell Disease. Transplant Infectious Disease. 2026. doi:10.1111/tid.70271

BibTeX
@article{Hijano2026,
  author = {Hijano, Diego R and Elgarten, Caitlin and Stenger, Elizabeth and Liu, Katie and Haight, Ann E and Parikh, Suhag H and Gliwinski, Julia and Wechsler, Laurence and Abraham, Allistair and Barreto, Mauricio and Olson, Timothy S and Maron, Gabriela and Sharma, Akshay},
  title = {Invasive Pneumococcal Disease After Hematopoietic Cell Transplantation for Sickle Cell Disease},
  journal = {Transplant Infectious Disease},
  year = {2026},
  doi = {10.1111/tid.70271}
}
Kostenlos starten →